TP53 and central nervous system cancer: In glioma cells expressing wild‐type TP53, but not in a TP53‐mutant background, miR‐517c inhibits the activation of autophagy causing a disturbance of the nuclear translocation of TP53 that in turn blocks mesenchymal transformation and autophagy‐induced invasion (Lu et al., 2015).